In a pivotal three-day diplomatic engagement held in early March 2025, the Kingdom of Belgium and the World Health Organization (WHO) concluded a comprehensive strategic dialogue aimed at recalibrating their long-standing partnership. As the global health landscape undergoes rapid transformation—marked by emerging biological threats, the lingering effects of the COVID-19 pandemic, and the urgent need for universal health coverage (UHC)—the discussions served to harmonize Belgium’s development cooperation priorities with the WHO’s 14th General Programme of Work (GPW14).
The delegation, led by H.E. Christophe Payot, Ambassador of Belgium to the United Nations and other international organizations in Geneva, represented a unified Belgian front, incorporating expertise from the federal government as well as the Flemish and Walloon regional governments. The dialogue underscores Belgium’s enduring commitment to multilateralism and its role as a pivotal donor and strategic partner in the global health ecosystem.
Chronology of the Strategic Dialogue
The discussions, which spanned from March 2 to March 5, 2025, were meticulously structured to move from historical project reviews to future-oriented policy alignment.
- Day 1: Setting the Strategic Horizon. The opening sessions were dedicated to the evolving global health landscape. Discussions centered on how the WHO’s strategic directions, particularly under the newly unfolding GPW14, can be integrated into Belgium’s bilateral development frameworks. Both parties revisited the outcomes of the 2024 Belgian Presidency of the Council of the European Union, which prioritized health sovereignty and pandemic preparedness.
- Day 2: Operational Deep Dives. The second day focused on high-stakes technical areas, specifically the "Access to Medicines" program. The delegation examined real-world implementation case studies, notably from Senegal, to identify bottlenecks in the supply chain and local manufacturing efforts. Concurrent sessions explored the "One Health" approach, addressing the nexus between human, animal, and environmental health in the context of zoonotic spillover risks.
- Day 3: Institutional Future-Proofing. The final day shifted toward long-term institutional agreements. Participants reviewed the progress of the WHO-Belgium Country Cooperation Strategy, focusing on how to align WHO country office activities more tightly with Belgian bilateral aid in partner nations like the Democratic Republic of Congo and Mozambique. The dialogue concluded with a commitment to a renewed, multi-year framework agreement.
Equitable Access: Beyond the Rhetoric
A cornerstone of the Belgian-WHO dialogue was the critical assessment of equitable access to essential medicines and health technologies. The current "Access to Medicines" initiative, funded by Belgium, remains one of the most significant pillars of their partnership.
During the discussions, WHO technical experts presented a candid evaluation of the program’s current trajectory. The dialogue moved beyond simple funding metrics, shifting instead to the complexities of "market shaping." By leveraging data from Senegal, the WHO illustrated how local production is not merely a manufacturing challenge but a regulatory and political one. The partners agreed that for the initiative to be sustainable, it must transition from a donor-funded model to one that fosters regional health security. This involves reducing reliance on volatile global supply chains and empowering nations to develop the infrastructure necessary for indigenous production of vaccines and essential drugs.
Navigating the "Polycrisis": Emergencies and Pandemic Preparedness
The dialogue addressed the mounting pressure on the global health architecture. With ongoing negotiations for a global pandemic agreement, the Belgian delegation and the WHO explored how to institutionalize resilience.
A particularly sobering segment of the dialogue involved a review of the WHO’s emergency response efforts in Gaza. This served as a stark case study for the delegation regarding the challenges of operating in high-intensity conflict zones, where health infrastructure is systematically degraded. The discussion broadened to encompass the rising threat of "biological risks"—a catch-all term for the risks posed by both natural zoonoses and the potential for the accidental or intentional release of pathogens.
The WHO emphasized that its role in the future will be less about being the primary responder and more about being the "orchestrator" of global response capacity. Belgium reaffirmed its support for the One Health approach, which recognizes that the next pandemic is likely to originate in the interface between human encroachment and animal habitats.
Universal Health Coverage: A Path Toward Sustainability
The UHC-Partnership (UHC-P) remains a flagship element of the collaboration. Reviewing the 2021–2024 cycle, the partners noted that while progress has been made in strengthening primary health care (PHC) systems, there remains a disconnect between national policy and local implementation.
In the Democratic Republic of Congo, for example, the dialogue highlighted the difficulty of sustaining PHC gains in the face of local political instability. The participants analyzed how Belgian bilateral aid can be more effectively integrated with the WHO’s technical advisory work. A significant portion of this session was dedicated to mental health—a previously neglected, yet increasingly vital, component of UHC. By integrating mental health services into primary care, the partners aim to provide a more holistic health package that addresses the "silent" burden of disease.
Official Responses and Diplomatic Sentiment
The high-level participation from both the Belgian delegation and the WHO hierarchy underscored the importance of this dialogue.
Dr. Catharina Boehme, Assistant Director-General for External Relations and Governing Bodies at the WHO, was effusive in her acknowledgment of the Belgian contribution. "We thank you for your support, honesty, and strong engagement for global health," she noted. "Your efforts in supporting our work in Mozambique and Senegal are clear examples of the crucial work we accomplish together."
From the Belgian side, the tone was one of pragmatic optimism. Mr. Koen Van Acoleyen, Minister Counselor at the Permanent Representation of Belgium to the UN, highlighted the necessity of the partnership in navigating a fractured world. "After listening to the leaders and experts of WHO, we now better understand how they are navigating these challenging times," Van Acoleyen stated. "We are honoured that we can walk this road together."
Mr. Dirk Brems, Director of Thematic and Multilateral Cooperation at Belgium’s Directorate-General for Development Cooperation, echoed this sentiment, emphasizing the value of trust. "We recognize WHO as a trustworthy partner in global health. We felt proud hearing how crucial our support is to the Organization and how it is having a positive impact at country, regional, and global levels."
Implications for the Future of Global Health
The dialogue between Belgium and the WHO carries significant implications for the broader international community. As the world moves into the cycle defined by the 14th General Programme of Work (GPW14), the alignment between a mid-sized, influential European donor and the primary global health agency sets a precedent for how other nations might structure their international aid.
Key Implications Include:
- Strategic Alignment: By moving toward a renewed Country Cooperation Strategy, Belgium is signaling a shift away from fragmented project-based funding toward a more holistic, systems-strengthening approach.
- Evidence-Based Policy: The review of Neglected Tropical Diseases and Sexual, Reproductive Health and Rights (SRHR) programs highlighted a commitment to data-driven decision-making. The partners agreed that future funding must be tied to measurable outcomes rather than historical commitments.
- Strengthened Multilateralism: In an era where multilateralism is often challenged by protectionism and geopolitical tension, the explicit commitment of the Belgian government—representing its diverse regional interests—to the WHO serves as a stabilizing signal to the international health community.
- Prioritization under GPW14: The shared vision that Universal Health Coverage and health systems strengthening are the "heart" of the WHO’s future work ensures that Belgian aid will be directed toward the most critical bottleneck in global health: the capacity of sovereign states to provide for their own populations.
As the three-day summit concluded, the participants looked forward not just to the next fiscal year, but to a long-term future. The partnership is no longer just about filling funding gaps; it is about co-creating a resilient, adaptive, and equitable global health system capable of withstanding the shocks of the 21st century. The success of this collaboration will be tested in the coming years, but the foundation laid in Geneva suggests a robust, evidence-backed path forward.
About the Author
